Hogeling, S. M., Lê, D. M., Rose, N. L., Kwon, M. C., Wierenga, A. T., Heuvel, F. A. v. d., . . . Schuringa, J. J. Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationHogeling, Shanna M., et al. Bleximenib, the Novel Menin-KMT2A Inhibitor JNJ-75276617, Impairs Long-term Proliferation and Immune Evasion in Acute Myeloid Leukemia. Ferrata Storti Foundation.
MLA (9th ed.) CitationHogeling, Shanna M., et al. Bleximenib, the Novel Menin-KMT2A Inhibitor JNJ-75276617, Impairs Long-term Proliferation and Immune Evasion in Acute Myeloid Leukemia. Ferrata Storti Foundation.
Warning: These citations may not always be 100% accurate.